Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96649765 | 9664976 | 5 | F | 2013 | 20160824 | 20131101 | 20160901 | EXP | CA-ABBVIE-13P-028-1063548-00 | ABBVIE | 0.00 | F | Y | 61.74000 | KG | 20160901 | CN | COUNTRY NOT SPECIFIED | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 96649765 | 9664976 | 1 | PS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | Y | UNKNOWN | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | |||||
| 96649765 | 9664976 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | Y | UNKNOWN | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | |||||
| 96649765 | 9664976 | 3 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | Y | UNKNOWN | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW | |||||
| 96649765 | 9664976 | 4 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | Y | UNKNOWN | 125057 | 40 | MG | SOLUTION FOR INJECTION IN PRE-FILLED PEN | QOW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 96649765 | 9664976 | 1 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 96649765 | 9664976 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 96649765 | 9664976 | Carpal tunnel syndrome | |
| 96649765 | 9664976 | Erythema | |
| 96649765 | 9664976 | Foot deformity | |
| 96649765 | 9664976 | Gait disturbance | |
| 96649765 | 9664976 | Inappropriate schedule of drug administration | |
| 96649765 | 9664976 | Localised infection | |
| 96649765 | 9664976 | Pain in extremity | |
| 96649765 | 9664976 | Papule | |
| 96649765 | 9664976 | Peripheral swelling | |
| 96649765 | 9664976 | Rash |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 96649765 | 9664976 | 1 | 20120704 | 201302 | 0 | |
| 96649765 | 9664976 | 2 | 20151124 | 0 | ||
| 96649765 | 9664976 | 3 | 2016 | 0 | ||
| 96649765 | 9664976 | 4 | 201608 | 0 |